ALLERGY, cilt.77, sa.1, ss.197-206, 2022 (SCI-Expanded)
Background The success of subcutaneous immunotherapy (SCIT) mostly depends on regular injections. Our aim was to investigate adherence to SCIT with aeroallergens during the COVID-19 pandemic and demonstrate clinical consequences of treatment disruptions in real life.